Joachim Jankowski

A guide to uraemic toxicity

2,8-Dihydroxyadenine-induced nephropathy causes hexosylceramide accumulation with increased mTOR signaling, reduced levels of protective SirT3 expression and impaired renal mitochondrial function

Stimulation of the EP₃receptor causes lung oedema by activation of TRPC6 in pulmonary endothelial cells

Data Sharing Under the General Data Protection Regulation

Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions

Uremic Toxins and Ciprofloxacin Affect Human Tenocytes In Vitro

Quantitative Translation of Microfluidic Transporter <i>in Vitro</i> Data to <i>in Vivo</i> Reveals Impaired Albumin-Facilitated Indoxyl Sulfate Secretion in Chronic Kidney Disease

Comparison of Urine and Plasma Peptidome Indicates Selectivity in Renal Peptide Handling

Targeting proinflammatory cytokines ameliorates calcifying phenotype conversion of vascular progenitors under uremic conditions in vitro

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker

Disposition and clinical implications of protein-bound uremic toxins

Threonine 150 Phosphorylation of Keratin 5 Is Linked to Epidermolysis Bullosa Simplex and Regulates Filament Assembly and Cell Viability

Oxidative Stress in Chronic Kidney Disease

A urinary proteome-based classifier for the early detection of decline in glomerular filtration

Interaction of human serum albumin with short polyelectrolytes: a study by calorimetry and computer simulations

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy

Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration

Implementation of proteomic biomarkers: making it work

A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases